Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

High-Intensity Peripheral Magnetic Stimulation for Traumatic Nerve Injury

Official title: Clinical and Electrophysiological Evaluation of the Effect of High-Intensity Peripheral Magnetic Stimulation in Traumatic Peripheral Nerve Injury: A Randomized, Double-Blind, Sham-Controlled Trial

Run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · NCT07705490 · Data updated 2026-11-12

This study tests whether adding high-intensity peripheral magnetic stimulation to a structured exercise program can reduce pain and improve function for adults with a traumatic peripheral nerve injury.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorGaziler Physical Medicine and Rehabilitation Education and Research Hospital
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedAugust 13, 2026
Main results expectedJune 2027
Study endsJuly 2027
Registry record updatedSeptember 22, 2026
Trial IDNCT07705490 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-65 with unilateral traumatic peripheral nerve injury, DN4 ≥ 4, VAS ≥ 4, EMG-confirmed injury, and motor weakness (MRC < 5).

Probably not a fit

Patients with non-traumatic neuropathies, complete nerve injury, or contraindications to magnetic stimulation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, sham-controlled trial takes place at a single center and compares active high-intensity peripheral magnetic stimulation plus a standardized exercise program to sham stimulation plus the same exercise program in adults with unilateral traumatic peripheral nerve injury. Participants must have neuropathic pain, reduced muscle strength, and injury confirmation by EMG, with onset at least 3 months prior. The intervention consists of about 9 magnetic stimulation sessions over 3 weeks, delivered over the injured nerve, alongside daily personalized exercise therapy. Outcomes include pain, function, quality of life, and electrophysiological measures assessed at baseline, 4 weeks, and 8 weeks. Blinded assessors will evaluate outcomes to minimize bias.

Why it matters

Potential benefit: If successful, the approach could provide a non-invasive option to reduce pain and improve motor function after traumatic nerve injuries.

How similar studies have gone: Prior research on high-intensity magnetic stimulation for neuropathic pain and nerve rehabilitation has shown promise but is limited in traumatic nerve injury.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* Traumatic peripheral nerve injury
* Unilateral traumatic peripheral neuropathy confirmed by electromyography (EMG)
* Nerve injury occurring at least 3 months prior
* Douleur Neuropathique 4 (DN4) score ≥ 4
* Visual Analog Scale (VAS) score ≥ 4
* Manual Muscle Testing score \< 5
* No analgesic use, or stable analgesic therapy for the past month (no dose changes)

Exclusion Criteria:

* Active infection or malignancy
* Metal implant or shrapnel in the application area
* Electronic implants (e.g., cardiac pacemaker, spinal cord stimulator, deep brain stimulator)
* Central nervous system diseases
* Non-traumatic causes of neuropathy (e.g., radiculopathy, diabetic neuropathy, entrapment neuropathies, HIV-related neuropathy, trigeminal neuralgia)
* Complete nerve injury
* Injury involving three or more peripheral nerves or plexus injury
* History of peripheral nerve surgery or injection within the past 3 months
* Active psychiatric illness
* Coagulopathy

Where it's running

  • Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Nurdan Korkmaz — Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
  • Study coordinator: Hüseyin Anıl İnan, MD
  • Email: dranilinan@gmail.com
  • Phone: +905346159274

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.